Understanding the proposed product
Amniotic membrane is a tissue layer within the placenta. Processed products differ in composition, processing, and intended use. A tissue source alone does not establish that every product is suitable for the same purpose.
Part of a complete care plan
The clinician considers the wound’s diagnosis, condition, prior care, and the patient’s goals before recommending a product. Management of pressure, circulation, infection concerns, and other contributing factors remains essential.
A wound covering does not replace the rest of the treatment plan or ongoing clinical review.
Questions to discuss before treatment
- Which specific product is being considered, and what is its intended role?
- What are the relevant risks and alternatives for this wound?
- How will the wound’s response be assessed?
- What follow-up, coverage review, and patient costs should be discussed?
The clinician explains the recommendation and reassesses the plan as care progresses. An assessment does not guarantee a product will be recommended or covered.
Common questions
Does every chronic wound need a tissue-based product?
No. Products are considered only for selected wounds following clinical assessment. Other wound care approaches may be more appropriate.
Are all placental products equivalent?
No. Products differ. The treating clinician should explain the specific product, its intended use, relevant evidence, and limitations.
Further reading: FDA: Human tissue product guidance.